@ksqtx.com
KSQ is deploying its CRISPRomics platform, which pinpoints therapeutic nodes that directly correlate genomic function to disease, for new drug development.
📢
Find anything inaccurate?
If you spot any mistakes on this brand profile, report to us.
Brand Logos
View allLogo
PNG
Icon
JPEG
About
Description
KSQ Therapeutics Inc is a leading brand in the field of gene therapy and drug development. They utilize their innovative CRISPRomics platform to decode the genome and identify optimal gene targets for the treatment of oncology and autoimmune diseases. With their state-of-the-art drug development capabilities, including the first-in-class USP1 inhibitor KSQ-4279 and the eTIL autologous cell therapy platform, KSQ Therapeutics is at the forefront of rewiring human biology with the potential to cure diseases.
Their CRISPRomics platform allows them to supercharge the process of target and drug discovery, leading to the identification and validation of selective and potent targets for targeted cancer therapies and immuno-oncology therapies. Additionally, their eTIL autologous cell therapy candidates, KSQ-001 and KSQ-004, have shown promising results in preclinical models for the treatment of solid tumors. KSQ Therapeutics is dedicated to transforming the standard of care for patients by systematically discovering and pursuing the best therapeutic targets for disease intervention.
Their innovative approach provides a pipeline opportunity with significant curative potential for a wide range of human diseases
Company Type
Privately Held
Company Size
11-50
Year Founded
2015
Brand collections
View allLogos
Colors
Fonts
Images
Our mission is to keep every brand on-brand everywhere 👋
All services online